SVP, Clinical Development · NovaBridge Biosciences · Ordinary Shares
Side
M
Value
—
Shares
12.4K
Price
—
Executed
Jul 4, 2026
Disclosed
Jul 7, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jul 4 executedJul 7, 2026 disclosed
NBP · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 4.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Xu Cong Claire filed this Form 4 reporting a option exercise of NBP on Jul 4, 2026. It became public on Jul 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, Clinical Development
Xu Cong Clairecik:0002114309
Issuer
NovaBridge Biosciencescik:0001778016
Revision history · 0
No field has changed since this record was first ingested.
